Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

Clinical trial NCT03168815 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03168815
Sponsor: Mount Sinai Hospital, Canada
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Immunocompromised Hematologic Malignancy Post Hematopoietic Stem Cell Transplant Hypoxia Pulmonary Infiltrates

Start date: 2018-01-10
Primary completion: 2025-12-31
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.